[go: up one dir, main page]

GR1007712B - Pharmaceutical composition containing leukotriene receptor antagonist and method for the preparation thereof - Google Patents

Pharmaceutical composition containing leukotriene receptor antagonist and method for the preparation thereof

Info

Publication number
GR1007712B
GR1007712B GR20110100469A GR20110100469A GR1007712B GR 1007712 B GR1007712 B GR 1007712B GR 20110100469 A GR20110100469 A GR 20110100469A GR 20110100469 A GR20110100469 A GR 20110100469A GR 1007712 B GR1007712 B GR 1007712B
Authority
GR
Greece
Prior art keywords
preparation
receptor antagonist
leukotriene receptor
pharmaceutical composition
composition containing
Prior art date
Application number
GR20110100469A
Other languages
Greek (el)
Inventor
Ευαγγελος Ανδρεα Καραβας
Ευθυμιος Χρηστου Κουτρης
Ιωαννα Χρηστου Κουτρη
Βικυ Χρηστου Σαμαρα
Αναστασια Λεωνιδα Καλασκανη
Original Assignee
Φαρματεν Αβεε,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Φαρματεν Αβεε, filed Critical Φαρματεν Αβεε,
Priority to GR20110100469A priority Critical patent/GR1007712B/en
Publication of GR1007712B publication Critical patent/GR1007712B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a stable chewable pharmaceutical formulation comprising a therapeutically effective amount of a leukotriene receptor antagonist agent, and particularly Montelukast or a pharmaceutically acceptable salt or derivative thereof, and a process for the preparation thereof.
GR20110100469A 2011-08-03 2011-08-03 Pharmaceutical composition containing leukotriene receptor antagonist and method for the preparation thereof GR1007712B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20110100469A GR1007712B (en) 2011-08-03 2011-08-03 Pharmaceutical composition containing leukotriene receptor antagonist and method for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20110100469A GR1007712B (en) 2011-08-03 2011-08-03 Pharmaceutical composition containing leukotriene receptor antagonist and method for the preparation thereof

Publications (1)

Publication Number Publication Date
GR1007712B true GR1007712B (en) 2012-10-09

Family

ID=47321012

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20110100469A GR1007712B (en) 2011-08-03 2011-08-03 Pharmaceutical composition containing leukotriene receptor antagonist and method for the preparation thereof

Country Status (1)

Country Link
GR (1) GR1007712B (en)

Similar Documents

Publication Publication Date Title
WO2013188273A8 (en) Topical ophthalmological pharmaceutical composition containing axitinib
PH12014500200A1 (en) Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators
UA110310C2 (en) Compounds n-aryl triazole as antagonists receptors lisophosphatidic acid (lpar)
MX351305B (en) Mineralocorticoid receptor antagonists.
PH12015500460B1 (en) Coated pharmaceutical composition containing regorafenib
PH12013501557A1 (en) Glucagon receptor modulator
WO2013188268A8 (en) Topical ophthalmological pharmaceutical composition containing pazopanib
WO2013188283A8 (en) Topical ophthalmological pharmaceutical composition containing sunitinib
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
TN2013000533A1 (en) Topical ophthalmological pharmaceutical composition containing regorafenib
WO2012113850A3 (en) (PYRIDIN-4-YL)BENZYLAMIDES AS ALLOSTERIC MODULATORS OF ALPHA 7 nAChR
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
TN2015000280A1 (en) Topical Ophthalmological Pharmaceutical Composition containing Regorafenib
WO2013188279A8 (en) Topical ophthalmological pharmaceutical composition containing cediranib
GR1008228B (en) Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof
MX353991B (en) A 5-ht4 receptor agonist as a prokinetic agent.
MX2014000855A (en) Quinolinyl glucagon receptor modulators.
LT3882244T (en) Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient
GR1007712B (en) Pharmaceutical composition containing leukotriene receptor antagonist and method for the preparation thereof
WO2011139255A3 (en) Pharmaceutical compositions comprising cefetamet
GR1008169B (en) Pharmaceutical composition comprising a fluoroquinolone antibacterial agent and method for the preparation thereof
GR1007907B (en) Pharmaceutical composition containing a phenocarbamate acetylcholinesterase inhibitor
GR1008380B (en) Pharmaceutical composition comprising an antiviral agent and method for the preparation thereof
GR1007741B (en) Pharmaceutical composition containing an atypical antipsychotic agent and method for the preparation thereof
GR1007629B (en) Controlled-release pharmaceutical formulation of a non-ergoline dopamine agonist

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20121122

ML Lapse due to non-payment of fees

Effective date: 20170309